AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 36.00
0.00 (0.00%)
Sep 16, 2026, 3:06 PM JST
AnGes Market Cap
AnGes has a market cap or net worth of 14.36 billion as of September 15, 2026. Its market cap has decreased by -56.46% in one year.
Market Cap
14.36B
Enterprise Value
14.80B
Revenue
962.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.00
ChartMarket Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 14.36B, a decrease of -38.54%. That is a compound annual growth rate of -2.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 14.36B | -39.26% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 15.11B |
| CanBas | 14.12B |
| RaQualia Pharma | 14.11B |
| ReproCELL | 14.02B |
| StemRIM | 11.28B |
| Immuno-Biological Laboratories | 10.79B |
| Kubota Pharmaceutical Holdings | 10.70B |
| K Pharma,Inc. | 9.55B |